Darapladib China PK

NCT02000804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: darapladib 160mg

Sponsor

GlaxoSmithKline